Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.




This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

April 4, 2008

Xyzal--Just overpriced Zyrtec

This analysis is solely the work of the author. It has not been edited or endorsed by GLG.
Analysis By:
David Engler, MD, Physician, The Allergy ClinicDavid Engler, MD 
Physician, The Allergy Clinic
Implications:  A bottle of 30 Generic Zyrtec can be purchased for $15.  No one is going to get Xyzal that inexpensively. There are no head to head studies showing Xyzal to be better than Zyrtec.  Even though Xyzal claims a 6% sedation rate compared to Zyrtec's 14% rate, it's not apples to apples.  In the Zyrtec study, placebo made 8% sleepy, whereas placebo only made 2% sleepy in the Xyzal study. Thus, either way, the drug was much more sedating than the placebo.

Analysis:

 

Xyzal is no better than other antihistamines for tough to treat hives (urticaria).  What is an example of tough-to-treat hives?  How about familial cold urticaria.  When it gets cold, these poor folks get itchy hives popping up all over.  An old drug, Periactin, is about all that works.  Singulair was supposed to help a little, but doesn't reliably. Now comes Xyzal, telling us it's the best antihistamine ever.  After all, Xyzal is based on Zyrtec, and Zyrtec beat Allegra in each and every quantitative competition (where they saw which one inhibited allergy skin tests the most)         

But Xyzal suffered a knockout punch by all three of my familial cold urticaria patients.  It worked no better than Zyrtec, Allegra or Claritin.  And all of those are available as Generics.   


Other Analyses of the Same Source Article:
Hello, I'm here to sell you Allegra D, and Xyzal, but not Allegra or Zyrtec!
September 7, 2007, Author: David Engler, MD, Physician, The Allergy Clinic
"New kid in town"
August 31, 2007, Author: GLG Expert Contributor
Xyzal approval
August 30, 2007, Author: Mitchell Boxer, MD, Assistant Clinical Professor, Albert Einstein College of Medicine
The drug patent "shell game"
August 28, 2007, Author: Forrest Rubenstein, MD, Cardiac, Thoracic and Vascular Surgeon, Rubenstein Cardiovascular and Thoracic Surgery
Xyzal is a more or less unnecessary drug being added to a saturated market
August 27, 2007, Author: GLG Expert Contributor
Ateempt at End Run Around Patent Expiration Will Likely Fail
August 27, 2007, Author: GLG Expert Contributor
Better?
August 27, 2007, Author: GLG Expert Contributor
Xyzal: wait and watch before adoption.
August 27, 2007, Author: GLG Expert Contributor
Another Chiral Medication Without Significant Benefit
August 27, 2007, Author: GLG Expert Contributor

Report a Concern

GLG News: What Experts Think Is Important





Analytics